Sevelamer hydrochloride use in a toddler

Taiji Nakashima(Hokkaido University), Masahiro Ikeda(Pediatric Nephrology of Alabama), Yutaka Osako(Tokyo Metropolitan Kiyose Children's Hospital), Miwa Goto(Tokyo Metropolitan Kiyose Children's Hospital), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Masataka Honda(Rikkyo University), Haruko Nakata(Tokyo Metropolitan Kiyose Children's Hospital), Yuko Hamasaki(Toho University)
Nihon Toseki Igakkai Zasshi
January 1, 2005
10.4009/jsdt.38.219
Cited by 1

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts
|The Journal of Immunology|2012|205
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149